Background HPV16 is implicated in around 30% of oropharyngeal cancers (OPCs). HPV-associated OPCs generally show a better prognosis, but 20% deviate from this trend, indicating a need for better molecular pro ling. HPV16-E5 is an oncoprotein encoded by an mRNA that undergoes extensive splicing, with only one speci c transcript being translatable. The prognostic signi cance of this E5-productive transcript in HPV-related OPCs is not well-studied. Methods We retrospectively analysed 74 HPV16-positive OPC cases diagnosed between 2011 and 2021. FFPE tissue samples were used for p16, EGFR, and HLA-I analysis by immunohistochemistry while E5, productive E5, E6 and E7 transcripts were detected by qPCR. Survival analysis was conducted using Kaplan-Meier curves and log-rank tests. Results Productive HPV16-E5 transcripts were detected in 11.3% of OPCs. There was no signi cant association between HPV16-E5 transcripts and EGFR or HLA-I expression. However, the presence of the productive E5 transcript was associated with worse progression-free survival (PFS) (p = 0.0024). EGFR or HLA-I expression was not signi cantly associated with PFS (p = 0.17 and p = 0.93, respectively). Conclusions This study demonstrates for the rst time the presence of E5-productive transcripts in HPV16-positive OPCs and its association with poorer PFS, highlighting its potential as a prognostic marker. Further research with larger cohorts is needed to validate these ndings.
Detection and signficance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma
Ignazio La MantiaInvestigation
;
2025-01-01
Abstract
Background HPV16 is implicated in around 30% of oropharyngeal cancers (OPCs). HPV-associated OPCs generally show a better prognosis, but 20% deviate from this trend, indicating a need for better molecular pro ling. HPV16-E5 is an oncoprotein encoded by an mRNA that undergoes extensive splicing, with only one speci c transcript being translatable. The prognostic signi cance of this E5-productive transcript in HPV-related OPCs is not well-studied. Methods We retrospectively analysed 74 HPV16-positive OPC cases diagnosed between 2011 and 2021. FFPE tissue samples were used for p16, EGFR, and HLA-I analysis by immunohistochemistry while E5, productive E5, E6 and E7 transcripts were detected by qPCR. Survival analysis was conducted using Kaplan-Meier curves and log-rank tests. Results Productive HPV16-E5 transcripts were detected in 11.3% of OPCs. There was no signi cant association between HPV16-E5 transcripts and EGFR or HLA-I expression. However, the presence of the productive E5 transcript was associated with worse progression-free survival (PFS) (p = 0.0024). EGFR or HLA-I expression was not signi cantly associated with PFS (p = 0.17 and p = 0.93, respectively). Conclusions This study demonstrates for the rst time the presence of E5-productive transcripts in HPV16-positive OPCs and its association with poorer PFS, highlighting its potential as a prognostic marker. Further research with larger cohorts is needed to validate these ndings.| File | Dimensione | Formato | |
|---|---|---|---|
|
Don-_et_al-2025-BMC_Cancer.pdf
accesso aperto
Descrizione: Articolo in rivista
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
2.45 MB
Formato
Adobe PDF
|
2.45 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


